Authors' objectives:

To determine the effectiveness, safety and cost implications of vaccines in the current Malaysian immunisation schedule, as well as of other vaccines so as to revise the current immunisation schedule if necessary.

Authors' recommendations: Based on the evidence, the following is recommended: - Bacille Calmette-Gurein (BCG) vaccination - to be continued according to the current immunisation schedule - Diphtheria, Tetanus, and Pertussis (DPT) vaccine - accelerated immunisation schedule at 6 week, 3 month and 5 month with a booster at 12-24 months and another at 4-6 year. - Polio - the current schedule of OPV should be continued, while IPV can be given to immuno-compromised patient. - Measles, Mumps, Rubella (MMR) - the first dose should be given at 12 months, accept for Sabah where its proposed that it be given at 9 month. The second dose should be given at 6-7 year. - Hepatitis B - to continue the current universal immunisation schedule at 0, 1, & 6 month. - Hemophilus Influenza B (HIB) - HIB conjugate vaccine be given at 3, 4, 5 months with an additional dose at 12-15 months. - Japanese Encephalitis (JE) - for high risk areas only. JE vaccine to be administered with DPT booster at 18 months, followed by a second dose at 19 months and a booster at 30 months. - Hepatitis A universal vaccination is not recommended and should be given only in specific group e.g travellers. - Pneumococcal Vaccine - data on true burden of pneumococcal infection in children locally is needed before a policy can be formulated.

Authors' methods: Systematic review

Project Status: Completed

URL for project: http://www.moh.gov.my/

Year Published: 2001

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: Malaysia

Organisation Name: Malaysian Health Technology Assessment Unit

Contact Address: Health Technology Assessment Unit, Medical Development Division, Ministry of Health Malaysia, Level 21, PERKIM Building, Jalan Ipoh, 51200 Kuala Lumpur, Malaysia. Tel: 603 4045 7781, Fax: 603 4045 77 40

Copyright: Malaysian Health Technology Assessment Unit (MHTAU)